Myomo, Inc. (MYO)
After hours:
| Previous Close | 3.4200 |
| Open | 3.4300 |
| Bid | 3.3600 x 900 |
| Ask | 3.6100 x 1200 |
| Day's Range | 3.3600 - 3.5100 |
| 52 Week Range | 0.3710 - 5.5800 |
| Volume | |
| Avg. Volume | 279,015 |
| Market Cap | 97.711M |
| Beta (5Y Monthly) | 1.53 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Myomo Appoints Heather Getz to its Board of Directors
BOSTON, March 28, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors.
- Business Wire
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
BOSTON, March 07, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and year ended December 31, 2023.
- Business Wire
CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®
BOSTON, March 01, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that on February 29, 2024, the Centers for Medicare & Medicaid Services (CMS) posted the final Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule payment rates for the MyoPro®.
